Identification of interleukin-6 trans-signalling as a novel target for therapeutic approaches to lung cancer

  • Jenkins, Brendan (Primary Chief Investigator (PCI))
  • Rose-John, Stefan (Chief Investigator (CI))

Project: Research

Project Details

StatusFinished
Effective start/end date1/01/1431/12/16

Funding

  • National Health and Medical Research Council (NHMRC) (Australia): AUD606,226.00